全文获取类型
收费全文 | 48639篇 |
免费 | 3881篇 |
国内免费 | 126篇 |
专业分类
耳鼻咽喉 | 401篇 |
儿科学 | 1827篇 |
妇产科学 | 1480篇 |
基础医学 | 6784篇 |
口腔科学 | 668篇 |
临床医学 | 6108篇 |
内科学 | 9346篇 |
皮肤病学 | 812篇 |
神经病学 | 4753篇 |
特种医学 | 1225篇 |
外国民族医学 | 3篇 |
外科学 | 5123篇 |
综合类 | 697篇 |
一般理论 | 43篇 |
预防医学 | 5706篇 |
眼科学 | 919篇 |
药学 | 3182篇 |
中国医学 | 68篇 |
肿瘤学 | 3501篇 |
出版年
2023年 | 319篇 |
2022年 | 557篇 |
2021年 | 1119篇 |
2020年 | 711篇 |
2019年 | 1176篇 |
2018年 | 1268篇 |
2017年 | 909篇 |
2016年 | 1045篇 |
2015年 | 1088篇 |
2014年 | 1542篇 |
2013年 | 2279篇 |
2012年 | 3311篇 |
2011年 | 3458篇 |
2010年 | 1945篇 |
2009年 | 1614篇 |
2008年 | 2806篇 |
2007年 | 3010篇 |
2006年 | 2869篇 |
2005年 | 2783篇 |
2004年 | 2539篇 |
2003年 | 2387篇 |
2002年 | 2242篇 |
2001年 | 759篇 |
2000年 | 718篇 |
1999年 | 669篇 |
1998年 | 509篇 |
1997年 | 446篇 |
1996年 | 361篇 |
1995年 | 351篇 |
1994年 | 294篇 |
1993年 | 328篇 |
1992年 | 512篇 |
1991年 | 490篇 |
1990年 | 474篇 |
1989年 | 411篇 |
1988年 | 450篇 |
1987年 | 397篇 |
1986年 | 362篇 |
1985年 | 331篇 |
1984年 | 308篇 |
1983年 | 265篇 |
1982年 | 175篇 |
1980年 | 169篇 |
1979年 | 250篇 |
1978年 | 207篇 |
1977年 | 166篇 |
1976年 | 167篇 |
1975年 | 168篇 |
1974年 | 167篇 |
1973年 | 192篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Mohand Mesbah Ilka Nemere Petros Papagerakis Jean-Raphael Nefussi Silvana Orestes-Cardoso Catherine Nessmann Ariane Berdal 《Journal of bone and mineral research》2002,17(9):1588-1596
The calciotropic hormone 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] has been established to control skeletal tissue formation and biomineralization via the regulation of gene expression. This action involves the well-characterized nuclear 1,25(OH)2D3 receptor. However, it has been recognized that several cellular responses to 1,25(OH)2D3 may not to be related to the exclusive nuclear receptor. Indeed, this secosteroid is able to generate rapid responses that have been proposed to be mediated by interactions of the ligand, which is a putative cell membrane-associated rapid-response steroid (MARRS) binding protein for 1,25(OH)2D3 [1,25D3-MARRS]. The nongenomic pathway of 1,25(OH)2D3 was studied here in detail by immunolocalization of the 1,25D3-MARRS during the specific context of human prenatal development. Western blotting with proteins extracted from 4 week- to 27-week-old embryos was performed, evidencing a 65-kDa molecular species recognized by antibody Ab 099 generated against synthetic peptides corresponding to the N terminus of the 1,25D3-MARRS from chick intestinal basolateral membranes. Based on this biochemical conservation of protein in the human species, the temporospatial expression patterns were established in the craniofacial skeleton at the same ages. Comparative analysis was performed in teeth and bones from early morphogenesis to terminal cell differentiation and extracellular biomineralization. The data show the potential implication of 1,25D3-MARRS in the heterogeneous cell population including ameloblasts, odontoblasts, osteoblasts, and osteoclasts. The epithelial-mesenchymal cascade related to odontogenesis was coincident with a sequence of up- and down-regulation of immunoreactive 1,25D3-MARRS. Biomineralization was associated with a striking up-regulation in the adjoining secretory cells in all tissues. Finally, osteoclasts appeared also to express the 1,25D3-MARRS during these early phases of bone modeling. Previously obtained data of the nuclear vitamin D receptor (VDR) expression and this study on 1,25D3-MARRS suggest the existence of cross-talk between the genomic and nongenomic pathways during human development. 相似文献
73.
74.
75.
Christian J Streck Paxton V Dickson Catherine Y C Ng Junfang Zhou John T Gray Amit C Nathwani Andrew M Davidoff 《Clinical cancer research》2005,11(16):6020-6029
PURPOSE: Type I IFNs (IFN-alpha/beta) have shown significant antitumor activity in preclinical models but limited efficacy and significant toxicity in clinical trials. We hypothesized that the antitumor activity of type I IFNs could be enhanced by chronic, low-dose systemic delivery and sought to test this in murine neuroblastoma models. EXPERIMENTAL DESIGN: Continuous liver-generated expression of human IFN-beta (hINF-beta) was achieved through a gene therapy-mediated approach using adeno-associated virus vectors encoding hIFN-beta (AAV hINF-beta). Orthotopic localized retroperitoneal and disseminated models of neuroblastoma were established using three different xenografts. Immunohistochemical analysis and ELISA were used to evaluate the antiangiogenic effect of therapy. RESULTS: The development of both localized orthotopic (retroperitoneal) and disseminated neuroblastoma was prevented in all mice expressing hINF-beta. Continued growth of established retroperitoneal tumors, treated with AAV hINF-beta as monotherapy, was significantly restricted, and survival for mice with established, disseminated disease was significantly prolonged following administration of AAV hINF-beta. Analysis of treated tumors revealed a significant antiangiogenic effect. Mean intratumoral vessel density was diminished and expression of the angiogenic factors vascular endothelial growth factor and basic fibroblast growth factor were both decreased. Finally, combination therapy in which AAV hIFN-beta was used together with low-dose cyclophosphamide resulted in regression of both established retroperitoneal and disseminated disease. CONCLUSIONS: AAV-mediated delivery of hIFN-beta when used as monotherapy was able to restrict neuroblastoma growth due in part to inhibition of angiogenesis. When used in combination with conventional chemotherapy, AAV hIFN-beta was able to effect complete tumor regression. 相似文献
76.
To study the effects of electroconvulsive therapy (ECT) on hormone release, we measured circulating concentrations of adrenocorticotropic hormone (ACTH), prolactin (PRL), growth hormone (GH) and cortisol (CORT) immediately before and at 2 min, 5 min, 15 min, and 30 min following ECT. Compared to pre-ECT concentrations, there were significant increases in post-ECT plasma ACTH, PRL and CORT. GH did not change consistently. No significant difference between unilateral and bilateral ECT was observed. Compared to the first ECT, repeated treatments were associated with a significant decrease in the magnitude of hormone surge. These hormonal changes induced by ECT may reflect changes at the neurotransmitter level. 相似文献
77.
Permeability of human brain tumor to 99mTc-gluco-heptonate and 99mTc-albumin. Implications for monoclonal antibody therapy 总被引:1,自引:0,他引:1
The variable penetration of chemotherapeutic drugs into brain and tumor is more dependent upon lipid solubility than upon size. In contrast, the molecular weight of virus- and tumor-specific monoclonal antibodies appears to limit uptake. The authors have studied eight patients with malignant brain tumors in order to compare tumor uptake of an iodinated contrast agent evaluated by computerized tomography scanning with uptake of the low and high molecular weight imaging agents technetium-99m (99mTc)-glucoheptonate and 99mTc-albumin, respectively, measured by radionuclide brain scanning. The agent 99mTc-labeled albumin was chosen for evaluation because its molecular weight (68,000) is similar to that of the most clinically promising monoclonal antibody fragment, the immunoglobulin (Ig) G Fab monomeric fragment. The radionuclide brain scans in the eight patients showed highly variable permeability of brain tumor to these markers, with uptake of the high molecular weight marker in the tumor being much less than that of the low molecular weight radionuclide. A clinical implication of these studies is that the success of monoclonal antibody therapy in the treatment of malignant brain tumors may require techniques to increase permeability of the blood-brain barrier and blood-tumor barrier to protein. 相似文献
78.
79.
80.